CIK 0001447362
- Accelerated filer
CASTLE BIOSCIENCES INC
Sign in to watch- Ticker
- CSTL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770701774
- Phone
- +1 866-788-9007
- Business address
- 1500 W. PARKWOOD AVE., SUITE 400, FRIENDSWOOD, TX, 77546
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,826,653
- in 18 filings, $4.9M under 10b5-1 plans
Net −$5,826,653. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-22 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale | −4,987 | $74.94 | $374K | 486,018 |
| 2021-06-17 | KABAKOFF DAVID S Director | Sale | −30,000 | $75.07 | $2.3M | 503,577 |
| 2021-06-17 | Juvenal Tobin W Chief Commercial Officer | Option exercise | +5,263 | $2.36 | $12K | 8,090 |
| 2021-06-17 | Juvenal Tobin W Chief Commercial Officer | Option exercise | +4,737 | $2.39 | $11K | 12,827 |
| 2021-06-17 | Juvenal Tobin W Chief Commercial Officer | Sale | −10,000 | $75.40 | $754K | 2,827 |
| 2021-06-17 | Juvenal Tobin W Chief Commercial Officer | Option exercise · Stock option (right to buy) | −5,263 | 479 | ||
| 2021-06-17 | Juvenal Tobin W Chief Commercial Officer | Option exercise · Stock option (right to buy) | −4,737 | 12,695 | ||
| 2021-06-17 | Stokes Frank Chief Financial Officer | Option exercise | +1,273 | $2.39 | $3K | 7,193 |
| 2021-06-17 | Stokes Frank Chief Financial Officer | Sale | −1,273 | $73.00 | $93K | 5,920 |
| 2021-06-17 | Stokes Frank Chief Financial Officer | Option exercise · Stock option (right to buy) | −1,273 | 25,137 | ||
| 2021-06-16 | Stokes Frank Chief Financial Officer | Option exercise | +2,127 | $2.39 | $5K | 8,047 |
| 2021-06-16 | Stokes Frank Chief Financial Officer | Sale | −2,127 | $73.07 | $155K | 5,920 |
| 2021-06-16 | Stokes Frank Chief Financial Officer | Option exercise · Stock option (right to buy) | −2,127 | 26,410 | ||
| 2021-06-15 | Stokes Frank Chief Financial Officer | Option exercise | +11,600 | $2.39 | $28K | 17,520 |
| 2021-06-15 | Stokes Frank Chief Financial Officer | Sale | −11,600 | $73.02 | $847K | 5,920 |
| 2021-06-15 | Stokes Frank Chief Financial Officer | Option exercise · Stock option (right to buy) | −11,600 | 28,537 | ||
| 2021-06-10 | KABAKOFF DAVID S Director | Grant or award · Stock option (right to buy) | +3,379 | 3,379 | ||
| 2021-06-10 | KABAKOFF DAVID S Director | Grant or award · Restricted Stock Units | +830 | 830 | ||
| 2021-06-10 | Harrison Miles Director | Grant or award · Stock option (right to buy) | +3,379 | 3,379 | ||
| 2021-06-10 | Harrison Miles Director | Grant or award · Restricted Stock Units | +830 | 830 |
Page 109 of 114 · 2,263 trades